China Shineway Pharmaceutical Group Limited (C1S) — Capital Reinvestment Ratio

Latest as of June 2023: 0.15x

China Shineway Pharmaceutical Group Limited (C1S) has a Capital Reinvestment Ratio of 0.15x as of June 2023, meaning it reinvests 0% of its operating cash flow (€160.69 Million) in capital expenditures (€24.57 Million). See C1S equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.15x
Capex / Operating Cash Flow

Operating Cash Flow

€160.69 Million
EUR

Capital Expenditures

€24.57 Million
EUR

Data as of

Jun 2023
Most recent filing

China Shineway Pharmaceutical Group Limited Capital Reinvestment Ratio (2013–2025)

This chart tracks China Shineway Pharmaceutical Group Limited's Capital Reinvestment Ratio across 13 annual periods. Check cash flow reinvestment rate of China Shineway Pharmaceutical Group Limi to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for China Shineway Pharmaceutical Group Limited (2013–2025)

Year-by-year Capital Reinvestment Ratio for China Shineway Pharmaceutical Group Limited from 2013 to 2025. For live market cap and broader valuation context, see how much is China Shineway Pharmaceutical Group Limi worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.17x €1.17 Billion €197.91 Million ▲ +16.1%
2024 0.15x €963.13 Million €140.11 Million ▼ -6.0%
2023 0.15x €932.63 Million €144.32 Million ▲ +32.6%
2022 0.12x €1.11 Billion €129.46 Million ▼ -12.4%
2021 0.13x €703.15 Million €93.63 Million ▲ +28.8%
2020 0.10x €638.57 Million €66.03 Million ▼ -57.0%
2019 0.24x €368.00 Million €88.40 Million ▲ +0.5%
2018 0.24x €532.59 Million €127.34 Million ▲ +27.8%
2017 0.19x €490.65 Million €91.83 Million ▲ +28.5%
2016 0.15x €733.53 Million €106.79 Million ▲ +1.7%
2015 0.14x €744.71 Million €106.56 Million ▲ +6.2%
2014 0.13x €773.16 Million €104.18 Million ▼ -73.3%
2013 0.50x €519.89 Million €261.89 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow